A Perimenopausal Woman With a Small, ER/HER2-Positive, Node-Negative Breast Cancer

被引：0
作者：
Brooks, Gabriel [6 ]
Borges, Virginia
Singh, Meenakshi [5 ]
Rabinovitch, Rachel [4 ]
Finlayson, Christina [3 ]
Elias, Anthony [1 ,2 ]
机构：
[1] Univ Colorado, Ctr Canc, Div Med Oncol, Sch Med, Aurora, CO 80045 USA
[2] Univ Colorado, Breast Canc Res Program, Sch Med, Aurora, CO 80045 USA
[3] Univ Colorado, Sch Med, Dept Surg, Aurora, CO 80045 USA
[4] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO 80045 USA
[5] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80045 USA
[6] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA
来源：
ONCOLOGY-NEW YORK | 2008年 / 22卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1270 / 1276
页数：7
相关论文
共 39 条
  • [1] Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
  • [2] Amar S, 2007, BREAST CANCER RES TR, V106, pS254
  • [3] Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance
    Arpino, G
    Weiss, H
    Lee, AV
    Schiff, R
    De Placido, S
    Osborne, CK
    Elledge, RM
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (17): : 1254 - 1261
  • [4] Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases
    Bardou, VJ
    Arpino, G
    Elledge, RM
    Osborne, CK
    Clark, GM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) : 1973 - 1979
  • [5] Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
    Bartelink, H
    Horiot, J
    Poortmans, P
    Struikmans, H
    Van den Bogaert, W
    Barillot, I
    Fourquet, A
    Borger, J
    Jager, J
    Hoogenraad, W
    Collette, L
    Pierart, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) : 1378 - 1387
  • [6] Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7
  • [7] Black D, 2006, BREAST CANCER RES TR, V100, pS92
  • [8] Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
    Brenton, JD
    Carey, LA
    Ahmed, AA
    Caldas, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (29) : 7350 - 7360
  • [9] Carlson RW, 2008, NCCN CLIN PRACTICE G
  • [10] A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
    Coombes, RC
    Hall, E
    Gibson, LJ
    Paridaens, R
    Jassem, J
    Delozier, T
    Jones, SE
    Alvarez, I
    Bertelli, G
    Ortmann, O
    Coates, AS
    Bajetta, E
    Dodwell, D
    Coleman, RE
    Fallowfield, LJ
    Mickiewicz, E
    Andersen, J
    Lonning, PE
    Cocconi, G
    Stewart, A
    Stuart, N
    Snowdon, CF
    Carpentieri, M
    Massimini, G
    Bliss, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) : 1081 - 1092
1234